Skip to content
Review

Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes

Sep 2026 · Drugs · Vol 86, pp. 1795 - 1812 · 0 citations · 125 references
Medicine

TL;DR

Traditional treatments such as dietary fiber, probiotics, antispasmodics, laxatives, laxatives, prokinetics, antidepressants, antibiotics, and antihistamines are reviewed, emphasizing the limited and often inconsistent evidence supporting their use for pain relief and overall symptom improvement.

View source

Similar papers

Review Open access Aug 2026

IRRITABLE BOWEL SYNDROME IN CHILDREN: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT

This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions.

Agata Leszek, Michał Stermach, Z. Lecyk et al. · 0 citations
Review Open access Aug 2026

Irritable Bowel Syndrome (IBS) and its management by the Unani System of Medicine: A Review

Background: Irritable Bowel Syndrome (IBS) is a functional gastrointestinal condition that is very common, relapses frequently, and severely lowers a patient's quality of life. IBS is still a treatment issue in contemporary gastroenterology. It is characterized by stomach pain, bloating, and changed bowel habits withou...

Faiyaz Ahmad, V. Singh, Amreen Fatima et al. · 0 citations
Review Open access Aug 2026

The Potential of Complementary and Alternative Therapies in Improving Diarrhea-Predominant Irritable Bowel Syndrome: Strategies for Long-Term Efficacy

The findings suggest that traditional Chinese medicine, acupuncture, and dietary interventions can provide sustained relief from core symptoms of IBS-D, including diarrhea and abdominal pain.

Yu-Qing Deng, Xin-Yi Ao, Xin Liang et al. · 0 citations
Review Open access Aug 2026

EFFICACY OF ANTIDEPRESSANTS IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW

Antidepressants appear to have a role in IBS management, with the most consistent evidence observed for TCAs, and Interpretation is constrained by variability in outcome measures and study design.

Marzena Chrapczyńska, Agnieszka Filarecka, Piotr Przybyszewski et al. · 0 citations
Review Open access Sep 2026

Rome Criteria for irritable bowel syndrome, fifth revision: Key updates. A review

The Rome V Criteria, published in 2026, updates the scientific and clinical understanding of irritable bowel syndrome (IBS). It redefines IBS from a “functional disorder” to a “gut-brain interaction disorder,” emphasizing biological underpinnings. Recognized pathophysiological mechanisms include impaired motility, alte...

Tatiana B. Topchii, M. Ardatskaya, L. N. Maslovskii et al. · 0 citations
Review Open access Sep 2026

Melatonin Supplementation in the Management of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

BACKGROUND Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction characterized by recurrent abdominal pain and altered bowel habits, with substantial effects on quality of life and healthcare utilization. Melatonin has been proposed as a potential adjunctive therapy because of its effects on visc...

Ghadeer Mahdi, Noor Abotaiban, A. Gadelmawla et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.